N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143380 |
| CAS No | NA |
| Mol.F. | C23H31N7O6S |
| Mol.Wt. | 533.60 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143381 |
| CAS No | NA |
| Mol.F. | C21H27N7O5S |
| Mol.Wt. | 489.55 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143382 |
| CAS No | NA |
| Mol.F. | C25H33N7O4 |
| Mol.Wt. | 495.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143383 |
| CAS No | NA |
| Mol.F. | C18H19N5O5 |
| Mol.Wt. | 385.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143384 |
| CAS No | NA |
| Mol.F. | C23H31N7O6S |
| Mol.Wt. | 533.60 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143385 |
| CAS No | NA |
| Mol.F. | C21H25N7O6S |
| Mol.Wt. | 503.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143386 |
| CAS No | NA |
| Mol.F. | C17H17N5O5 |
| Mol.Wt. | 371.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143387 |
| CAS No | NA |
| Mol.F. | C23H29N7O7S |
| Mol.Wt. | 547.59 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143388 |
| CAS No | NA |
| Mol.F. | C21H25N7O8S |
| Mol.Wt. | 535.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143389 |
| CAS No | NA |
| Mol.F. | C17H21N5O4 |
| Mol.Wt. | 359.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143390 |
| CAS No | NA |
| Mol.F. | C25H33N7O2S2 |
| Mol.Wt. | 527.71 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143391 |
| CAS No | NA |
| Mol.F. | C6H13N3O |
| Mol.Wt. | 143.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143392 |
| CAS No | NA |
| Mol.F. | C16H16N4O4 |
| Mol.Wt. | 367.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143393 |
| CAS No | NA |
| Mol.F. | C31H45N3O8 |
| Mol.Wt. | 587.7 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143394 |
| CAS No | 23595-00-8 |
| Mol.F. | C14H9F3N2O3 |
| Mol.Wt. | 310.2 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143395 |
| CAS No | NA |
| Mol.F. | C18H29N3O4 |
| Mol.Wt. | 351.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |